-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- A New Association Wants YOU! Calling all Supporters of Citizen Science! in Work In Progress
- Help stop fat bullying in Work In Progress
- Childhood obesity drops 40% in the last decade. Or not really, but who's checking? in Work In Progress
- 3 Ways to Bridge the Behaviour-Intention Gap in Work In Progress
- The worst thing you can eat is sugar: an update in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.